Benzinga | Nov 16, 2020 10:21AM EST

B of A Securities Maintains Buy on Sage Therapeutics, Raises Price Target to $95

B of A Securities maintains Sage Therapeutics (NASDAQ:SAGE) with a Buy and raises the price target from $72 to $95.